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a pandemic situation, the rapid virucidal activity provides
a decided advantage in reducing Inﬂuenza transmission via
hand contact.248 14
nformed consent. Plasma HIV-1 RNA levels were estimated
y Amplicor HIV-1 Monitor test V 1.5 (Roche Diagnostics).
IV-1 pol gene, enconsisting protease region (codons;1-99)
nd RT region (codons;1-232 to 1-239) was reverse tran-
cribed, followed by nested PCR with self designed primers.
he PCR product was sequenced with an ABI PRISM 3100
enetic analyzer system.
Results: The median HIV-1 RNA levels were log10 4.6
opies/ml (IQR; 4.2-5.3). All patients were found to be
nfected with HIV-1 subtype C. Only one (1.4%) study
equence harbored resistance-associated mutations in RT
egion, showing NRTI resistance mutation (M184I). No muta-
ion at major resistance positions in protease region was
etected. High rate of polymorphisms were observed at
odons; 35, 39, 40, 48, 60, 121, 122, 123, 135, 166, 173,
74, 177, 185, 200, 204, 206, 207, 208, 211, 216, 217, 233
239 in RT gene and 12, 15, 18, 19, 36, 38, 41, 63, 69, 70,
9 & 93 in protease gene.
Conclusion: The overall prevalence of transmitted
esistance-associated mutations was found to be 1.4%, lower
han the alert cut off of 5% deﬁned by WHO. HIV-1 sub-
ype C exhibited enormous polymorphism in RT and protease
egions of pol gene as compared to subtype B.
oi:10.1016/j.ijid.2010.02.2039
nfection Control, Nosocomial Infections and Critical
are (Poster Presentation)
6.001
linical, radiological and microbiological corroboration to
ssess the role of endotracheal aspirate in diagnosing
entilator-associated pneumonia in an intensive care unit
f a tertiary care hospital, India
. Mukhopadhyay ∗, S. Krishna, A. Shenoy, K. Prakashini
Kasurba Medical College, Manipal, India
Background: Early and accurate diagnosis and follow up
f VAP varies considerably with the clinical, radiological and
icrobiological criteria employed.
Methods: This study was aimed to correlate clinico-
adiological ﬁndings with microscopy and quantitative
ulture of consecutive ETA from 50 mechanically ventilated
atients along with the antibiogram and risk factor assess-
ent.
Results: The prospective observational study in MICU
evealed the incidence of VAP to be 42% with a rate of
16/1000 ventilator days. 8 had early onset and 13 late
nset VAP, with no age or sex signiﬁcant preponderance. The
ttributable mortality rate was 61.9% which rose with dura-
ion of stay. The important independent risk factors were
ulti-organ failure, reintubation and pleural effusion. The
ost commonly isolated organisms were multidrug resistant
cinetobacter baumannii (76%) and Pseudomonas aerugi-
osa (42%). All enterobacterial isolates were ESBL producing
nd all S. aureus isolates were methicillin resistant. In 66%,
olonization on day 1 resulted in development of VAP on day
. Gram stain ﬁndings had a signiﬁcant correlation with the
uantitative culture of ETA, which by itself showed a signif-
cantly progressive increase in speciﬁcity in diagnosing VAP
n day 7. The strength of association between CPIS scoring,
dternational Congress on Infectious Diseases (ICID) Abstracts
he microbiological ﬁndings and the clinical diagnosis was
ound to be strong.
Conclusion: This study emphasizes that Gram stain and
uantitative culture of ETA can be considered useful for the
iagnosis of VAP and a combined clinical, radiological and
icrobiological approach can be successful in the manage-
ent and further follow up of VAP.
oi:10.1016/j.ijid.2010.02.2040
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irucidal efﬁcacy of topical antiseptics versus a novel
train of Inﬂuenza H1N1
. Dzyakanava1,∗, K. Burningham2, J. Stahl3
BioScience Laboratories, Bozeman, MT, USA
Bioscience Laboratories, Bozeman, MT, USA
3M Company, Saint Paul, MN, USA
Background: On April 11, 2009 the WHO raised the epi-
emic alert to Phase 6 and declared a pandemic of novel
nﬂuenza H1N1. During the impending inﬂuenza season, the
umber of ‘‘swine’’ inﬂuenza cases is expected to increase,
mphasizing the importance to public health of contact and
espiratory hygiene. This study evaluated the susceptibility
f Inﬂuenza H1N1 A/California/04/2009 strain to three topi-
al sanitizing products, designed for application in a variety
f public and healthcare settings.
Methods: ASTM E 1052-96, Standard Test Method for Efﬁ-
acy of Antimicrobial Agents against Viruses in Suspension,
as used to evaluate a non-medicated soap and three topical
ntiseptics: AvagardTM Surgical and Healthcare Personnel
and Antiseptic (1% Chlorhexidine Gluconate, 61% Ethanol);
vagardÔ Foam Instant Hand Antiseptic (62% Ethanol); and
vagardÔ D Instant Hand Antiseptic (61% Ethanol). All
roducts were tested at a 90% (v/v) concentration versus
nﬂuenza H1N1 A/California/04/2009 strain with exposures
f 30 seconds, 1minute, and 2minutes. Viral titers were cal-
ulated using the Spearman- Kärber Method.
Results: All products signiﬁcantly reduced infectivity
f the epidemic strain of Inﬂuenza H1N1. AvagardTM (1%
hlorhexidine Gluconate, 61% Ethanol) and AvagardTM D
61% Ethanol) produced 5.25 log10 (>99.999%) reduction
fter 30 second exposure, as well as after 1 and 2minute
xposures. AvagardÔ Foam (62% Ethanol) reduced the viral
opulation by 4.25 log10 (>99.99%) after 30 second, 1, and
minute exposures. Testing performed on non-medicated
oap revealed low virucidal efﬁcacy after short-term expo-
ures: 2.50 log10 (99.68%) reduction after 30 second and
minute exposures.
Conclusion: Signiﬁcant reduction (>99.99%) in the pop-
lation of A/California/04/2009 strain was achieved after
0 second exposures of the virus to the hand sanitizers. Inoi:10.1016/j.ijid.2010.02.2041
